These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1929255)

  • 21. Effects of DU-6859a, a new quinolone antimicrobial, on theophylline metabolism in in vitro and in vivo studies.
    Niki Y; Itokawa K; Okazaki O
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1751-5. PubMed ID: 9661016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between theophylline and enoxacin.
    Takagi K; Hasegawa T; Yamaki K; Suzuki R; Watanabe T; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):288-92. PubMed ID: 3165968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
    Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ozagrel (OKY-046), a thromboxane synthetase inhibitor, on theophylline pharmacokinetics in asthmatic patients.
    Kawakatsu K; Kino T; Yasuba H; Kawaguchi H; Tsubata R; Satake N; Oshima S
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):158-63. PubMed ID: 2338368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sparfloxacin pharmacokinetics in healthy volunteers: the influence of acidification and alkalinization.
    Kamberi M; Kotegawa T; Tsutsumi K; Nakamura K; Nakano S
    Eur J Clin Pharmacol; 1998 Oct; 54(8):633-7. PubMed ID: 9860151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of new quinolone antimicrobial agents and macrolide antibiotics on the clearance of theophylline].
    Honma M
    Nihon Rinsho; 1996 Nov; 54(11):3125-9. PubMed ID: 8950966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Fillastre JP; Montay G; Bruno R; Etienne I; Dhib M; Vivier N; Le Roux Y; Guimart C; Gay G; Schott D
    Antimicrob Agents Chemother; 1994 Apr; 38(4):733-7. PubMed ID: 8031038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of drug metabolism by quinolone antibiotics.
    Edwards DJ; Bowles SK; Svensson CK; Rybak MJ
    Clin Pharmacokinet; 1988 Sep; 15(3):194-204. PubMed ID: 3052987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effect of repirinast on the pharmacokinetics of theophylline in asthmatic patients.
    Takagi K; Kuzuya T; Horiuchi T; Nadai M; Apichartpichean R; Ogura Y; Hasegawa T
    Eur J Clin Pharmacol; 1989; 37(3):301-3. PubMed ID: 2558890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin.
    Kamberi M; Nakashima H; Ogawa K; Oda N; Nakano S
    Br J Clin Pharmacol; 2000 Feb; 49(2):98-103. PubMed ID: 10671902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of quinolones on xanthine pharmacokinetics.
    Robson RA
    Am J Med; 1992 Apr; 92(4A):22S-25S. PubMed ID: 1580270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theophylline and warfarin interaction studies with grepafloxacin.
    Efthymiopoulos C; Bramer SL; Maroli A; Blum B
    Clin Pharmacokinet; 1997; 33 Suppl 1():39-46. PubMed ID: 9433655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolone antimicrobial agents and theophylline.
    Niki Y; Hashiguchi K; Okimoto N; Soejima R
    Chest; 1992 Mar; 101(3):881. PubMed ID: 1541174
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of effect of gemifloxacin on the steady-state pharmacokinetics of theophylline in healthy volunteers.
    Davy M; Allen A; Bird N; Rost KL; Fuder H
    Chemotherapy; 1999; 45(6):478-84. PubMed ID: 10567778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The newest quinolone antibacterial agents and theophylline.
    Niki Y; Umeki S; Kawane H; Soejimai R
    Chest; 1989 Feb; 95(2):486. PubMed ID: 2914514
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone.
    Visser MR; Rozenberg-Arska M; Beumer H; Hoepelman IM; Verhoef J
    Antimicrob Agents Chemother; 1991 May; 35(5):858-68. PubMed ID: 1854167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of sparfloxacin against Mycobacterium leprae inoculated into footpads of nude mice.
    Gidoh M; Tsutsumi S
    Lepr Rev; 1992 Jun; 63(2):108-16. PubMed ID: 1322480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of quinolone resistance mechanisms in a sparfloxacin-resistant clinical isolate of Neisseria gonorrhoeae.
    Tanaka M; Nakayama H; Haraoka M; Nagafuji T; Saika T; Kobayashi I
    Sex Transm Dis; 1998 Oct; 25(9):489-93. PubMed ID: 9800262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased theophylline clearance in asthmatic patients due to terbutaline.
    Garty M; Paul-Keslin L; Ilfeld DN; Mazar A; Spitzer S; Rosenfeld JB
    Eur J Clin Pharmacol; 1989; 36(1):25-8. PubMed ID: 2917584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.